Regional tumor oximetry: 19F NMR spectroscopy of hexafluorobenzene

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 1, 1998, Pages 161-171

  Hunjan, Sandeep ^a   Mason, Ralph P ^a   Constantinescu, Anca ^a   Peschke, Peter ^b   Hahn, Eric W ^a,b   Antich, Peter P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Carbogen; Fluorine NMR; Magnetic resonance imaging; Oxygen tension; Tumor

Indexed keywords

CARBOGEN; CARBON DIOXIDE; FLUORINE; HEXAFLUOROBENZENE; OXYGEN;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIMETRY; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RAT; TISSUE OXYGENATION; TREATMENT PLANNING;

ANIMALS; CARBON DIOXIDE; FLUORINE; FLUOROCARBONS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OXYGEN; PARTIAL PRESSURE; PROSTATIC NEOPLASMS; RATS;

EID: 0032054171     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00020-0     Document Type: Article

References (52)

1. Coleman C. N. Hypoxia in tumors A paradigm for the approach to biochemical and physiological heterogeneity . J. Natl. Cancer Inst. 80:1988;310-317.
2. Reynolds T. Y., Rockwell S., Glazer P. M. Genetic instability induced by the tumor microenvironment. Cancer Res. 56:1996;5754-5757.
3. Denekamp J. Physiological hypoxia and its influence on radiotherapy. Steel G. G., Adams G. E., Horwich A. The biological basis of radiotherapy. 1989;115-134 Elsevier, Amsterdam.
4. Brown J. M., Giaccia A. J. Tumor hypoxia The picture has changed in the 1990s . Int. J. Radiat. Biol. 65:1994;95-102.
5. Gray L. H., Conger A., Ebert M., Hornsey S., Scott O. The concentration of oxygen dissolved in tissues at time of irradiation as a factor in radio-therapy. Br. J. Radiol. 26:1953;638-648.
6. Höckel M., Schlenger K., Aral B., Mitze M., Schäffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
7. Chapman J. D., Stobbe C. C., Arnfield M. R., Santus R., Lee J., McPhee M. S. Oxygen dependency of tumor cell killing in vitro by light activated photofrin II. Radiat. Res. 126:1991;73-79.
8. Stratford I. J., Adams G. E., Bremmer J. C. M., Cole S., Edwards H. S., Robertson N. S., Wood P. J. Manipulation and exploitation of the tumor environment for therapeutic benefit. Int. J. Radiat. Biol. 65:1994;85-94.
9. Giaccia A. J. Hypoxia stress proteins Survival of the fittest . Semin. Radiol. Oncol. 6:1996;46-58.
10. Gatenby R. A., Kessler H. B., Rosenblum J. S., Coia L. R., Moldofsky P. J., Hartz W. H., Broder G. Oxygen distribution in squamous cell carcinoma metastases and its relationship to the outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;831-838.
11. 2 tension measurements . Cancer Res. 51:1991;3316-3322.
12. 2 histography . Vaupel P. W., Kelleher D. K., Günderoth M. Tumor oxygenation. 1995;219-232 Gustav Fischer Verlag, New York.
13. Stone H. B., Brown J. M., Phillips T. P., Sutherland R. M. Oxygen in human tumors Correlations between methods of measurement and response to therapy . Radiat. Res. 136:1993;422-434.
14. Sostman H. D., Rockwell S., Sylva A. L., Madwed D., Cofer G., Charles H. C. Evaluation of BA 1112 rhabdomyosarcoma oxygenation with microelectrodes, optical spectrometry, radiosensitivity, and MRS. Magn. Reson. Med. 20:1991;253-267.
15. 2 in a murine fibrosarcoma. Radiat. Res. 120:1989;477-493.
16. 31P NMR measurements of changes in experimental tumor metabolism be related to modification of oxygenation status? Br. J. Radiol. (Suppl. 24):137-141; 1994.
17. Robinson S. P., Howe F. A., Griffiths J. R. Non-invasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;855-859.
18. Vexler V. S., de Crespigny A. J. S., Wendland M. F., Kuwatsuru R., Muhler A., Brasch R. C., Moseley M. E. MR imaging of blood oxygenation-dependent changes in focal renal ischemia and transplanted liver tumor in rat. J. Magn. Reson. Imaging. 3:1993;483-490.
19. Karczmar G. S., Kuperman V. Y., River J. N., Lewis M. Z., Lipton M. J. Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. Invest. Radiol. 29:1994;S161-S163.
20. Thomas S. R. The biomedical applications of fluorine-19 NMR. Partain C. L., Price R. R., Patton J. A., Kulkarni M. V., James A. E. Jr. Magnetic resonance imaging. 1988;1536-1552 W. B. Saunders, London.
21. 19F NMR of perfluorocarbon . Artif. Cells Blood Sub. Immob. Biotechnol. 22:1994;1141-1153.
22. Dardzinski B., Sotak C. H. Evaluating changes in murine tumor oxygenation in response to nicotinamide by using F-19 EPI and spectroscopy. Magn. Reson. Med. 32:1994;88-97.
23. Fishman J. E., Joseph P. M., Carvlin M. J., Saadi-Elmandjra M., Mukherji B., Sloviter H. S. In vivo measurements of vascular oxygen tension in tumors using MRI of a fluorinated blood substitute. Invest. Radiol. 24:1989;65-71.
24. Mason R. P., Antich P. P., Babcock E. E., Constantinescu A., Peschke P., Hahn E. W. Non-invasive determination of tumor oxygen tension and local variation with growth. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;95-103.
25. 31P magnetic resonance spectroscopy. Magn. Reson. Imaging. 14:1996;541-551.
26. 19F NMR relaxometry of a perfluorocarbon emulsion. Magn. Reson. Med. 29:1993;303-310.
27. 19F surface coil spectroscopy of sequestered perfluorocarbon emulsion . Magn. Reson. Med. 18:1991;71-79.
28. 19F MRI study in tumor-bearing mice . Magn. Reson. Imaging. 7:1989;475-485.
29. Lutz J., Stark M. Half life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats. Pflugers Arch. 401:1987;181-184.
30. 19F NMR indicator of tumor oxygenation . NMR Biomed. 9:1996;125-134.
31. Hahn E. W., Peschke P., Mason R. P., Babcock E. E., Antich P. P. Isolated tumor growth in a surgically formed skin pedicle in the rat A new tumor model for NMR studies . Magn. Reson. Imaging. 11:1993;1007-1017.
32. Van Uijen C. M. J., Den Boef J. H. Driven equilibrium radio-frequency pulses in NMR imaging. Magn. Reson. Med. 1:1984;502-507.
33. 31P-MR spectroscopy and in-vivo radiosensitivity . Vaupel P. W., Kelleher D. K., Günderoth M. Tumor oxygenation. 1995;95-105 Gustav Fisher, Stuttgart.
34. Yeh K. A., Biade S., Lanciano R. M., Brown D. Q., Fenning M. C., Babb J. S., Hanks G. E., Chapman J. D. Polarographic needle electrode measurements of oxygen in rat prostate carcinomas Accuracy and reproducibility . Int. J. Radiat. Oncol. Biol. Phys. 33:1995;111-118.
35. Cater D., Silver I. Quantitative measurements of oxygen tension in normal tissues and in the tumors of patients before and after radiotherapy. Acta Radiol. 53:1960;233-256.
36. 2 and radiosensitivity of tumors by fluosol and carbogen. Cancer Res. 47:1987;442-446.
37. Haldane J. S., Priestley J. G. The regulation of lung ventilation. J. Physiol. 32:1905;225-266.
38. 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn. Reson. Med. 32:1994;88-97.
39. Endo K., Yamamoto K., Kado R. Fluorine-19 NMR relaxation analysis of the interaction of fluorocarbon with oxygen. Anal. Sci. 9:1993;47-51.
40. Lartigau E., Lespinasse F., Vitu L., Guichard M. Does the direct measurement of oxygen tension in tumors have adverse effects? Int. J. Radiat. Oncol. Biol. Phys. 22:1992;949-951.
41. Mortelmanns K. M. In vitro microbiological mutagenicity assays of eight fluorocarbon taggent samples. Gov. Rep. Announce. Index US. 81:1981;2555.
42. Courtney K. D., Andrews J. E. Teratogenic evaluation and fetal deposition of hexabromobenzene (HBB) and hexafluorobenzene in CD-1 mice. J. Environ. Sci. Health B. 19:1984;83-94.
43. Grossman Y. S., Kapitonenko T. A. Pharmacology and toxicology of hexafluorobenzene. Izv. Estestvonnonauchu. Inst. Pevinsk. 15:1973;155-163.
44. Hall L. W., Jackson S. R. K., Massey G. M. Hexafluorobenzene in veterinary anaesthesia. Arias A., Llaurado R., Nalda M. A., Lunn J. N. Excerpta medica. 1975;201-204 Oxford University Press, New York.
45. Saunders M., Dische S. Clinical results of hypoxic cell sensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide. Br. J. Cancer. 74:1996;S271-S278.
46. Ewing J. R., Branch C. A., Fagan S. C., Helpern J. A., Simkins R. T., Butt S. M., Welch K. M. A. Fluorocarbon-23 measure of cat cerebral blood flow by NMR. Stroke. 21:1990;100-106.
47. Peschke P., Lohr F., Hahn E., Wolber G., Hoever K., Wenz F., Lorenz W. Response of the rat Dunning R3327-AT1 prostate tumor to treatment with fractionated fast neutrons. Radiat. Res. 129:1992;112-114.
48. Mueller-Klieser W., Vaupel P. Spontaneous variations of blood supply and tissue temperature in peripheral subcutaneous tumors during anesthesia. Kallman R. Rodent tumor models in experimental cancer therapy. 1987;43-46 Pergamon, New York.
49. Griffiths J., Bhujwalla Z., Coombes R., Maxwell R., Midwood C., Morgan R., Nias A., Perry P., Prior M., Prysor-Jones R., Rodrigues L., Stubbs M., Tozer G. Monitoring cancer therapy by NMR spectroscopy. Ann. NY Acad. Sci. 508:1988;182-199.
50. Thews O., Kelleher D. K., Vaupel P. W. Intra- and inter-tumor variability of oxygenation Quantification and evaluation of minimum number of electrode tracks for representative measurements . Vaupel P. W., Kelleher D. K., Günderoth M. Tumor oxygenation. 1995;39-47 Gustav Fischer Verlag, New York.
51. Griffiths J. R., Taylor N. J., Howe F. A., Saunders M. I., Robinson S. P., Hoskins P. J., Powell M. E. B., Thoumine M., Caine L. A., Baddeley H. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;697-701.
52. 19F PBSR EPI of hexafluorobenzene . Magn. Reson. Imaging. 15:1997;971-981.